Bayer looks to leverage synergies from Life Sciences to drive innovation & business

摘要

Nearly ten years after Bayer spun off its chemicals, commodity polymers, synthetic rubbers, fine chemicals and custom services business to create a company that eventually became Lanxess, it is again reinventing itself. In September this year, it announced that Bayer MaterialScience (BMS), with 2013 sales of ?11.2-bn, 28% of total revenues, will be listed as a separate entity, possibly by early 2016. The complex exercise, currently underway, will leave Bayer as a Life Science focussed company, with twin businesses of HealthCare (BHC) and CropScience (BCS) - catering to human, animal and plant health.